; HTC cells were from D. K. Granner (3). Both cell lines were grown as monolayer cultures in plastic dishes (60 by 15 mm or 100 by 15 mm) (Falcon) in Ham nutrient medium F-10, supplemented with 15% horse serum and 2.5% fetal calf serum, at 37 C under a humidified atmosphere of 95% air and 5% CO2. For each experiment, equal numbers of cells (about 106/plate) were distributed into parallel plates, and the cultures were allowed to grow to near stationary phase before use. Prior to the addition of amphotericin B (Fungizone, Squibb Co.) or dexamethasone phosphate (Merck), the cultures were incubated for 24 h, after a fresh change of tissue culture medium, to allow cellular enzyme activity to return to a stable base-line value after its elevation associated with the change of medium. After the incubation period with amphotericin or steroid, the cells were removed from plates by trypsinization, sedimented, washed twice in a phosphate-buffered saline solution, and then sonically treated with a Biosonic IV ultrasonic disruptor microtip at a setting of 3 for 15 s. This was sufficient to disrupt greater than 90% of the cells. The cells were then centrifuged, and the resultant supernatant was used for assay of enzymatic activity. Each 60-by 15-mm plate of MHC cells was assayed individually in duplicate for TAT activity, and each experimental variable was tested in triplicate or more. Since the specific activity of TAT in HTC cells is less than that of MHC cells, two 100-by 15-mm plates of HTC cells were required for each individual assay.
Amphotericin B is one of the polyene antibiotics and is widely used for the treatment of systemic fungal infections. It is also commonly used in tissue culture for the prevention or treatment of yeast infections. We observed recently that, when a clonal strain of rat hepatoma cells (MHC) in tissue culture was exposed to amphotericin B, there was a reduction of both intracellular uninduced and dexamethasone-induced cellular tyrosine aminotransferase (EC 2.6.1.5; TAT) activities during the early incubation period (2 to 4 h) of cells with amphotericin, followed by an induction of enzyme activity with longer exposure (24 to 48 h) to the antifungal agent. Since that time, another clonal strain of an ascites form of the rat hepatoma (HTC) was tested similarly, and only reduction of induced enzyme activity could be demonstrated. This report (presented in part at the 12th Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlantic City, N.J., 26 to 29 September 1972) describes and compares the enzymatic responses of these two cell lines to amphotericin B and provides evidence that the underlying mechanisms responsible for the cellular responses may be different for steroids and amphotericin B.
MATERIALS AND METHODS Tissue culture methods. MHC cells were obtained from A. H. Tashjian, Jr. (9) ; HTC cells were from D. K. Granner (3) . Both cell lines were grown as monolayer cultures in plastic dishes (60 by 15 mm or 100 by 15 mm) (Falcon) in Ham nutrient medium F-10, supplemented with 15% horse serum and 2.5% fetal calf serum, at 37 C under a humidified atmosphere of 95% air and 5% CO2. For each experiment, equal numbers of cells (about 106/plate) were distributed into parallel plates, and the cultures were allowed to grow to near stationary phase before use. Prior to the addition of amphotericin B (Fungizone, Squibb Co.) or dexamethasone phosphate (Merck), the cultures were incubated for 24 h, after a fresh change of tissue culture medium, to allow cellular enzyme activity to return to a stable base-line value after its elevation associated with the change of medium. After the incubation period with amphotericin or steroid, the cells were removed from plates by trypsinization, sedimented, washed twice in a phosphate-buffered saline solution, and then sonically treated with a Biosonic IV ultrasonic disruptor microtip at a setting of 3 for 15 s. This was sufficient to disrupt greater than 90% of the cells. The cells were then centrifuged, and the resultant supernatant was used for assay of enzymatic activity. Each 60-by 15-mm plate of MHC cells was assayed individually in duplicate for TAT activity, and each experimental variable was tested in triplicate or more. Since the specific activity of TAT in HTC cells is less than that of MHC cells, two 100-by 15-mm plates of HTC cells were required for each individual assay.
Assay of TAT activity. A slight modification of the method of Hayashi et al. was used (4) for the assay of TAT activity. The reaction medium consisted of 0.1 ml of cytosol and 0.9 ml of a 0.05 M phosphate-buffered solution containing 5 x 10-i M L-tyrosine, 6 x TYROSINE AMINOTRANSFERASE ACTIVITY 241 ate, and 1 mg of bovine serum albumin per ml, at a final pH of 7.6. The reaction was begun by adding the substrate mixture to the enzyme solution; the tubes were then incubated at 37 C in a water bath for 15 min before 2.0 ml of 1.0 N NaOH was added to stop the reaction. After the addition of alkali, the mixture was allowed to incubate for 30 min more before the samples were removed and their absorptions at 331 nm were determined in an Acta II (Beckman) spectrophotometer. In control samples, the NaOH was added prior to the substrate mixture. The results were expressed as milliunits of enzyme activity per milligram of cytosol protein (determined by the Lowry method [8] ) per 15-min incubation period as defined previously [4] .
Some of the variation seen in the specific activities of TAT between experiments is probably due to differences between the enzyme activities of cells, depending on whether they were in the stationary or logarithmic stages of growth at the time they were used for experiments. In addition, some subclonal lines of cells showed increases and others showed decreases in basal and induced enzyme activities with varying periods of time (weeks or months) in culture. Within each experiment, however, these variations rarely exceeded 10%.
Media and chemicals. Ham nutrient mixture F-10 and the horse and fetal calf sera were purchased from Gibco Chemical Co. The Charity Waymouth medium (MAP 924/L) used in some of the serumless media experiments was made from stock chemicals (General Biochemicals) as detailed previously (la When MHC cells are first exposed to amphotericin B, the TAT activity is reduced as compared to that of cells incubated with amphotericin for longer periods of time (Fig. 3) , when the enzyme activity becomes greater than that of untreated cells. The inhibitory effects can be observed with amphotericin B concentrations as low as 5.0 Ag/ml (Table 2) . Dexamethasone-induced TAT activity in MHC cells is also decreased by amphotericin B during the early incubation period, but this reduced activity seems to recover at a much faster rate than that of uninduced activity ( Table 3) .
Some of the variation in enzyme activity observed in the experiments is probably due to differences in serum components that are capable of binding or inactivating amphotericin B.
When serum is completely removed from the medium, not only is the early reduction of cellular TAT activity further increased, but there is in addition no rebound increase in enzyme activity with longer incubation times of' amphotericin and cells ( Fig.-1 . The amphotericin was added either at day 0 (bottom) or day 7 (top), and cell counts were done as described in Fig. 1 (Fig. 4) DISCUSSION The use of amphotericin B for the prevention or treatment of yeast infections in tissue culture is a commonly accepted practice. Although concentrations above 5 ug/ml are not recommended for routine prophylaxis, it has been suggested that concentrations of amphotericin B as high as 40 ,ug/ml or more are without effect on the growth of several tissue cultured cell lines, and that concentrations of 20 ,ug/ml do not interfere with the growth of some enteric viruses in tissue culture (5). The major differences between these previous studies and our findings with MHC cells probably involve the use of fibroblastic types of cells in the former studies and our use of a cell line which expresses a variety of differentiated functions in tissue culture and which probably has a more amphotericin B-sensitive cell membrane. We have also observed growth inhibition of amphotericin B-treated adrenal cells in concentrations as low as 5 ,ug/ml (2) , while confirming the lack of effect of amphotericin B concentrations of 20 to 40 Ag/ml on the growth of HeLa, WI-38, and two glial cell lines. The lack of significant inhibition of the growth of HTC cells may reflect the relatively less well-differentiated nature of this cell line and presumably, therefore, a more amphotericin B-resistant cell membrane.
Effects on cellular growth rates are fairly crude parameters with which to evaluate the toxic or other effects of a given substance. As the results of the studies reported here demonstrate, amphotericin B, although having no effect on the growth of HTC cells or its unin- duced TAT activity, was capable of significant inhibition of a much more sensitive cellular system, i.e., induced enzyme activity. MHC cells demonstrated not only an amphotericin B-related growth inhibition, but also that basal and steroid-induced TAT activities were decreased soon after the addition of the antifungal agent to the tissue culture medium. With continued incubation of amphotericin B and MHC, but not HTC cells, cellular TAT activity not only returned to normal, but it actually increased over that of control values. A comparison of the effects of amphotericin B and dexamethasone strongly suggests that their mechanisms of increasing TAT activity are different. Lee and Kenney have shown recently that leucine and insulin are also capable of inducing TAT activity in HTC cells by mechanisms that must be different to those mediated by steroids (7), and our experimental results with MHC cells would suggest that additional mechanisms are involved in order to explain the effects of amphotericin B. What these molecular effects are remain to be determined. In preliminary experiments, both cell permeability and protein synthesis were found to be reduced in cells treated with amphotericin B for 2 h, whereas they were increased in cells treated for 48 thought to be the principle mechanisms of toxicity to both fungal (6) and mammalian cells (11) . Clearly, further studies of the effects of agents such as actinomycin D and cycloheximide on the amphotericin B-mediated alterations of intracellular TAT activity are necessary to define the molecular mechanisms by which these alterations are effected. The results of these types of studies should result not only in a greater understanding of amphotericin B's effects on TAT, but perhaps in an increased understanding of how the induction of TAT or, mote broadly, how differentiated functions, are regulated.
It has been suggested that amphotericin B may be a hepatoxic agent (1), but documentation of this toxic manifestation has not been adequate. Althotgh our results with HTC and MHC cells imply that there may be subtle hepatotoxic effects, the pattern of alterations of enzyme activity in MHC cells suggests that these cells are capable of adapting to the induced changes. An understanding of the mechanisms by which this adaptation occurs would seem to be of fundamental importance to the further understanding of the regulation of cellular functions.
